Small molecules in hematology. (2018)

• Record Type: Book
• Further Information: Note: Uwe M. Martens, editor.
• Editors: Martens, Uwe M
• Contents: Imatinib Mesylate -- Dasatinib -- Nilotinib -- Bosutinib: a potent second-generation tyrosine kinase inhibitor -- Ponatinib: a third-generation inhibitor for the treatment of CML -- Ruxolitinib -- Ibrutinib -- Pomalidomide -- Enasidenib -- Midostaurin: a multiple kinases inhibitor in acute myeloid leukemia and systemic mastocytosis -- Venetoclax: targeting BCL2 in hematological cancers -- Idelalisib -- Carfilzomib -- Acalabrutinib, a second-generation Bruton's tyrosine kinase inhibitor.
• Edition: Third edition
• Publisher Details: Cham, Switzerland : Springer
• Publication Date: 2018
• Extent: 1 online resource
• Subjects: 616.99/4061; Medicine; Cancer -- Molecular aspects; Cancer -- Treatment; Antineoplastic agents; Hematology; Oncology ; HEALTH & FITNESS -- Diseases -- General; MEDICAL -- Clinical Medicine; MEDICAL -- Diseases; MEDICAL -- Evidence-Based Medicine; MEDICAL -- Internal Medicine; Antineoplastic agents; Hematology; Medical -- Oncology; Oncology; Medical -- Hematology; Haematology; Neoplasms -- drug therapy; Antineoplastic Agents; Hematology; Electronic books
• Languages: English
• ISBNs: 9783319914398; 3319914391
• Related ISBNs: 9783319914381; 3319914383
• Notes: Note: Includes bibliographical references.; Note: Vendor-supplied metadata.
• Access Rights: Legal Deposit; Only available on premises controlled by the deposit library and to one user at any one time; The Legal Deposit Libraries (Non-Print Works) Regulations (UK).
• Access Usage: Restricted: Printing from this resource is governed by The Legal Deposit Libraries (Non-Print Works) Regulations (UK) and UK copyright law currently in force.